Clinical study on Tangweikang in treating diabetic gastroparesis.
- Author:
Rong-Qin JIANG
1
;
De-Xian ZHANG
;
Chun-Ying BAI
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Antiemetics; therapeutic use; Diabetes Complications; drug therapy; Domperidone; therapeutic use; Drug Therapy, Combination; Drugs, Chinese Herbal; therapeutic use; Female; Gastroparesis; drug therapy; etiology; Humans; Male; Middle Aged; Phytotherapy; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2007;27(2):114-116
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate clinical effects and mechanism of Tangweikang (TWK) in treating diabetic gastroparesis.
METHODSNinety diabetic gastroparesis patients were randomly assigned to 3 groups. Besides conventional hypoglycemic treatment, the 30 patients in the treated group were given TWK and the 30 in the control group were given Domperidone additionally, while to the 30 in the blank group, no additional drug was given. The clinical efficacy and the changes in level of motilin and gastric emptying rate were observed.
RESULTSTWK showed significant effects in improving clinical symptoms of patients, increasing gastric emptying rate, promoting gastrointestinal kinetics, shortening gastric emptying time and was beneficial to the control of blood sugar, including the 2 h post-prandial blood sugar and fructosamine. The curative rate and total effective rate in the treated group were 63.33% (19/30) and 93.33% (29/30) respectively, significantly different to those in the control group 26.67% (8/30) and 63.33%, also different to those in the blank group 23.33% (3/ 30) and 10.00%, respectively (P < 0.01). The clinical efficacy in the treated group was superior to that in the other two groups.
CONCLUSIONTWK has favorable therapeutic efficacy in treating DGP.
